Company Research Report: BlueWhale Bio, Inc.
Company Overview
- Name: BlueWhale Bio, Inc.
- Mission: BlueWhale Bio is dedicated to accelerating the growth and adoption of cell-based therapies. The company aims to address critical shortcomings in the current treatment paradigm by developing groundbreaking products that deliver the full benefits of cell therapy to more patients, faster and at lower costs.
- Founded: The exact founding date is not provided. The company was recently spun out of the University of Pennsylvania.
- Founders: The founding scientific team includes world-renowned immunotherapy pioneers Carl June and James Riley.
- Key People:
- Carl June, Richard W. Vague Professor in Immunotherapy at the Perelman School of Medicine, University of Pennsylvania.
- James Riley, Professor of Microbiology, University of Pennsylvania.
- Peter Keller, CEO.
- Headquarters: 2929 Arch Street, Philadelphia, PA 19104, USA.
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: BlueWhale Bio is known for its innovative platform to develop the next generation of cell and gene therapies, addressing manufacturing challenges in efficacy, durability, and cost.
Products
- Products Offered: BlueWhale Bio is developing a portfolio of groundbreaking products in cell and gene therapy to address manufacturing challenges. Specific products are not listed in the available information.
- High-Level Description: The company focuses on creating cell-based therapy solutions that are more effective, durable, and cost-efficient.
- Key Features: As products are yet in development or not specified, key features are not available.
Recent Developments
- Recent Developments:
- BlueWhale Bio was founded with $18 million in seed financing led by Danaher Ventures and other notable investors including Novalis LifeSciences and Marshall Wace.
- The company is the first to emerge from the Danaher Ventures Pioneer Program, which focuses on developing and commercializing disruptive products and services.
- New Products Launched: No specific information about newly launched products is available.
- New Features Added: No information is available on new features added to existing products.
- New Partnerships: The company has notable collaboration due to its emergence from the Danaher Ventures Pioneer Program.
This report is based entirely on the available data provided. For more information or media inquiries, visit the company's website or contact them via email at media@bluewhale.bio.
